Blogs

The exchange of information between companies as part of a merger or acquisition may be prohibited. This blog summarises the main points for attention. View blog >

The NZa will change its healthcare-specific merger test as of 1 July 2022 on three points. The changes are addressed in this blog. View blog >

ACM and the European Commission are focusing their attention on abuse of a dominant position in the pharmaceutical sector. This blog lists the lessons that pharmaceutical companies can learn from the supervision by ACM and the Commission. View blog >

Court of Appeal rules that Buma/Stemra abused its dominant position in relation to suppliers of background music by applying unequal conditions to streaming services. Read more in this blog. View blog >

This blog concerns the Unfair Practices Act an de prohibition of abuse of dominance. It also addresses producer organisations, sustainability initiatives and below-cost sales. View blog >

The Wet veiligheidstoets investeringen, fusies en overnames (Investments, Mergers and Acquisitions (Security Test) Act – the “Vifo Act”) introduces a test for investments in vital providers and sensitive technologies. This blog addresses the scope of application and the main points for attention of the Vifo Act. View blog >

Commission proposal to broaden current protected geographical indications scheme. This blog addresses the relationship between the cartel prohibition and quality schemes. View blog >